Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.330
+0.030 (2.31%)
Mar 6, 2026, 4:00 PM EST - Market closed
APUS Market Cap
APUS has a market cap or net worth of $16.73 million as of March 6, 2026.
Market Cap
16.73M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since the IPO on December 9, 2025, APUS's market cap has decreased from $26.79M to $16.73M, a decrease of -37.56%. That is a compound annual growth rate of -86.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 16.73M | -18.90% |
| Dec 31, 2025 | 20.62M | -23.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Talphera | 40.43M |
| Zhengye Biotechnology Holding | 35.54M |
| Rockwell Medical | 34.13M |
| SCYNEXIS | 33.57M |
| BioXcel Therapeutics | 32.37M |
| Aytu BioPharma | 27.05M |
| TherapeuticsMD | 26.04M |
| Caring Brands | 12.53M |